Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?
Blinman P, Hughes B, Crombie C, Christmas T, Hudson M, Veillard AS, Muljadi N, Millward M, Wright G, Flynn P, Windsor M, Stockler M, McLachlan SA; Australasian Lung Cancer Trials Group (ALTG).
Blinman P, et al. Among authors: christmas t.
Eur J Cancer. 2015 Aug;51(12):1529-37. doi: 10.1016/j.ejca.2015.05.022. Epub 2015 Jun 6.
Eur J Cancer. 2015.
PMID: 26059196